【市場調査レポート】 5HT3受容体拮抗薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global 5HT3 Receptor Antagonists Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。5HT3受容体拮抗薬のグローバル市場インサイト・予測（～2028年） / Global 5HT3 Receptor Antagonists Market Insights, Forecast to 2028 / QY2207E09209資料のイメージです。

• レポートコード：QY2207E09209
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の5HT3受容体拮抗薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に5HT3受容体拮抗薬の世界市場のxxx％を占める「ドラセトロン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の5HT3受容体拮抗薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの5HT3受容体拮抗薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの5HT3受容体拮抗薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

5HT3受容体拮抗薬のグローバル主要メーカーには、Otsuka Pharmaceutical、MedKoo Biosciences、Cipla、Helsinn Healthcare SA、Sanofi、Roche Holding AG、Kyowa Kirin、Heron Therapeutics、GlaxoSmithKline、Fortovia Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

5HT3受容体拮抗薬市場は、種類と用途によって区分されます。世界の5HT3受容体拮抗薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ドラセトロン、グラニセトロン、オンダンセトロン、パロノセトロン

【用途別セグメント】
病院薬局、ドラッグストア、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 5HT3受容体拮抗薬製品概要
- 種類別市場（ドラセトロン、グラニセトロン、オンダンセトロン、パロノセトロン）
- 用途別市場（病院薬局、ドラッグストア、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の5HT3受容体拮抗薬販売量予測2017-2028
- 世界の5HT3受容体拮抗薬売上予測2017-2028
- 5HT3受容体拮抗薬の地域別販売量
- 5HT3受容体拮抗薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別5HT3受容体拮抗薬販売量
- 主要メーカー別5HT3受容体拮抗薬売上
- 主要メーカー別5HT3受容体拮抗薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ドラセトロン、グラニセトロン、オンダンセトロン、パロノセトロン）
- 5HT3受容体拮抗薬の種類別販売量
- 5HT3受容体拮抗薬の種類別売上
- 5HT3受容体拮抗薬の種類別価格
・用途別市場規模（病院薬局、ドラッグストア、その他）
- 5HT3受容体拮抗薬の用途別販売量
- 5HT3受容体拮抗薬の用途別売上
- 5HT3受容体拮抗薬の用途別価格
・北米市場
- 北米の5HT3受容体拮抗薬市場規模（種類別、用途別）
- 主要国別の5HT3受容体拮抗薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの5HT3受容体拮抗薬市場規模（種類別、用途別）
- 主要国別の5HT3受容体拮抗薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の5HT3受容体拮抗薬市場規模（種類別、用途別）
- 主要国別の5HT3受容体拮抗薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の5HT3受容体拮抗薬市場規模（種類別、用途別）
- 主要国別の5HT3受容体拮抗薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの5HT3受容体拮抗薬市場規模（種類別、用途別）
- 主要国別の5HT3受容体拮抗薬市場規模（トルコ、サウジアラビア）
・企業情報
Otsuka Pharmaceutical、MedKoo Biosciences、Cipla、Helsinn Healthcare SA、Sanofi、Roche Holding AG、Kyowa Kirin、Heron Therapeutics、GlaxoSmithKline、Fortovia Therapeutics
・産業チェーン及び販売チャネル分析
- 5HT3受容体拮抗薬の産業チェーン分析
- 5HT3受容体拮抗薬の原材料
- 5HT3受容体拮抗薬の生産プロセス
- 5HT3受容体拮抗薬の販売及びマーケティング
- 5HT3受容体拮抗薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 5HT3受容体拮抗薬の産業動向
- 5HT3受容体拮抗薬のマーケットドライバー
- 5HT3受容体拮抗薬の課題
- 5HT3受容体拮抗薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global 5HT3 Receptor Antagonists Market
The global 5HT3 Receptor Antagonists market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Dolasetron accounting for % of the 5HT3 Receptor Antagonists global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China 5HT3 Receptor Antagonists market size is valued at US$ million in 2021, while the North America and Europe 5HT3 Receptor Antagonists are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe 5HT3 Receptor Antagonists landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global 5HT3 Receptor Antagonists market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global 5HT3 Receptor Antagonists market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global 5HT3 Receptor Antagonists market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global 5HT3 Receptor Antagonists market.
Global 5HT3 Receptor Antagonists Scope and Market Size
5HT3 Receptor Antagonists market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global 5HT3 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Dolasetron
Granisetron
Ondansetron
Palonosetron
Segment by Application
Hospital Pharmacy
Drugstore
Others
By Company
Otsuka Pharmaceutical
MedKoo Biosciences
Cipla
Helsinn Healthcare SA
Sanofi
Roche Holding AG
Kyowa Kirin
Heron Therapeutics
GlaxoSmithKline
Fortovia Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 5HT3 Receptor Antagonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dolasetron
1.2.3 Granisetron
1.2.4 Ondansetron
1.2.5 Palonosetron
1.3 Market by Application
1.3.1 Global 5HT3 Receptor Antagonists Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Drugstore
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global 5HT3 Receptor Antagonists Market Perspective (2017-2028)
2.2 5HT3 Receptor Antagonists Growth Trends by Region
2.2.1 5HT3 Receptor Antagonists Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 5HT3 Receptor Antagonists Historic Market Size by Region (2017-2022)
2.2.3 5HT3 Receptor Antagonists Forecasted Market Size by Region (2023-2028)
2.3 5HT3 Receptor Antagonists Market Dynamics
2.3.1 5HT3 Receptor Antagonists Industry Trends
2.3.2 5HT3 Receptor Antagonists Market Drivers
2.3.3 5HT3 Receptor Antagonists Market Challenges
2.3.4 5HT3 Receptor Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 5HT3 Receptor Antagonists Players by Revenue
3.1.1 Global Top 5HT3 Receptor Antagonists Players by Revenue (2017-2022)
3.1.2 Global 5HT3 Receptor Antagonists Revenue Market Share by Players (2017-2022)
3.2 Global 5HT3 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by 5HT3 Receptor Antagonists Revenue
3.4 Global 5HT3 Receptor Antagonists Market Concentration Ratio
3.4.1 Global 5HT3 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 5HT3 Receptor Antagonists Revenue in 2021
3.5 5HT3 Receptor Antagonists Key Players Head office and Area Served
3.6 Key Players 5HT3 Receptor Antagonists Product Solution and Service
3.7 Date of Enter into 5HT3 Receptor Antagonists Market
3.8 Mergers & Acquisitions, Expansion Plans
4 5HT3 Receptor Antagonists Breakdown Data by Type
4.1 Global 5HT3 Receptor Antagonists Historic Market Size by Type (2017-2022)
4.2 Global 5HT3 Receptor Antagonists Forecasted Market Size by Type (2023-2028)
5 5HT3 Receptor Antagonists Breakdown Data by Application
5.1 Global 5HT3 Receptor Antagonists Historic Market Size by Application (2017-2022)
5.2 Global 5HT3 Receptor Antagonists Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America 5HT3 Receptor Antagonists Market Size (2017-2028)
6.2 North America 5HT3 Receptor Antagonists Market Size by Type
6.2.1 North America 5HT3 Receptor Antagonists Market Size by Type (2017-2022)
6.2.2 North America 5HT3 Receptor Antagonists Market Size by Type (2023-2028)
6.2.3 North America 5HT3 Receptor Antagonists Market Share by Type (2017-2028)
6.3 North America 5HT3 Receptor Antagonists Market Size by Application
6.3.1 North America 5HT3 Receptor Antagonists Market Size by Application (2017-2022)
6.3.2 North America 5HT3 Receptor Antagonists Market Size by Application (2023-2028)
6.3.3 North America 5HT3 Receptor Antagonists Market Share by Application (2017-2028)
6.4 North America 5HT3 Receptor Antagonists Market Size by Country
6.4.1 North America 5HT3 Receptor Antagonists Market Size by Country (2017-2022)
6.4.2 North America 5HT3 Receptor Antagonists Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe 5HT3 Receptor Antagonists Market Size (2017-2028)
7.2 Europe 5HT3 Receptor Antagonists Market Size by Type
7.2.1 Europe 5HT3 Receptor Antagonists Market Size by Type (2017-2022)
7.2.2 Europe 5HT3 Receptor Antagonists Market Size by Type (2023-2028)
7.2.3 Europe 5HT3 Receptor Antagonists Market Share by Type (2017-2028)
7.3 Europe 5HT3 Receptor Antagonists Market Size by Application
7.3.1 Europe 5HT3 Receptor Antagonists Market Size by Application (2017-2022)
7.3.2 Europe 5HT3 Receptor Antagonists Market Size by Application (2023-2028)
7.3.3 Europe 5HT3 Receptor Antagonists Market Share by Application (2017-2028)
7.4 Europe 5HT3 Receptor Antagonists Market Size by Country
7.4.1 Europe 5HT3 Receptor Antagonists Market Size by Country (2017-2022)
7.4.2 Europe 5HT3 Receptor Antagonists Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 5HT3 Receptor Antagonists Market Size (2017-2028)
8.2 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Type
8.2.1 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Type (2017-2022)
8.2.2 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Type (2023-2028)
8.2.3 Asia-Pacific 5HT3 Receptor Antagonists Market Share by Type (2017-2028)
8.3 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Application
8.3.1 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Application (2017-2022)
8.3.2 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Application (2023-2028)
8.3.3 Asia-Pacific 5HT3 Receptor Antagonists Market Share by Application (2017-2028)
8.4 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Region
8.4.1 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Region (2017-2022)
8.4.2 Asia-Pacific 5HT3 Receptor Antagonists Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America 5HT3 Receptor Antagonists Market Size (2017-2028)
9.2 Latin America 5HT3 Receptor Antagonists Market Size by Type
9.2.1 Latin America 5HT3 Receptor Antagonists Market Size by Type (2017-2022)
9.2.2 Latin America 5HT3 Receptor Antagonists Market Size by Type (2023-2028)
9.2.3 Latin America 5HT3 Receptor Antagonists Market Share by Type (2017-2028)
9.3 Latin America 5HT3 Receptor Antagonists Market Size by Application
9.3.1 Latin America 5HT3 Receptor Antagonists Market Size by Application (2017-2022)
9.3.2 Latin America 5HT3 Receptor Antagonists Market Size by Application (2023-2028)
9.3.3 Latin America 5HT3 Receptor Antagonists Market Share by Application (2017-2028)
9.4 Latin America 5HT3 Receptor Antagonists Market Size by Country
9.4.1 Latin America 5HT3 Receptor Antagonists Market Size by Country (2017-2022)
9.4.2 Latin America 5HT3 Receptor Antagonists Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 5HT3 Receptor Antagonists Market Size (2017-2028)
10.2 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Type
10.2.1 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Type (2017-2022)
10.2.2 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Type (2023-2028)
10.2.3 Middle East & Africa 5HT3 Receptor Antagonists Market Share by Type (2017-2028)
10.3 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Application
10.3.1 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Application (2017-2022)
10.3.2 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Application (2023-2028)
10.3.3 Middle East & Africa 5HT3 Receptor Antagonists Market Share by Application (2017-2028)
10.4 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Country
10.4.1 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Country (2017-2022)
10.4.2 Middle East & Africa 5HT3 Receptor Antagonists Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Otsuka Pharmaceutical
11.1.1 Otsuka Pharmaceutical Company Details
11.1.2 Otsuka Pharmaceutical Business Overview
11.1.3 Otsuka Pharmaceutical 5HT3 Receptor Antagonists Introduction
11.1.4 Otsuka Pharmaceutical Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.1.5 Otsuka Pharmaceutical Recent Developments
11.2 MedKoo Biosciences
11.2.1 MedKoo Biosciences Company Details
11.2.2 MedKoo Biosciences Business Overview
11.2.3 MedKoo Biosciences 5HT3 Receptor Antagonists Introduction
11.2.4 MedKoo Biosciences Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.2.5 MedKoo Biosciences Recent Developments
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Cipla Business Overview
11.3.3 Cipla 5HT3 Receptor Antagonists Introduction
11.3.4 Cipla Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.3.5 Cipla Recent Developments
11.4 Helsinn Healthcare SA
11.4.1 Helsinn Healthcare SA Company Details
11.4.2 Helsinn Healthcare SA Business Overview
11.4.3 Helsinn Healthcare SA 5HT3 Receptor Antagonists Introduction
11.4.4 Helsinn Healthcare SA Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.4.5 Helsinn Healthcare SA Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi 5HT3 Receptor Antagonists Introduction
11.5.4 Sanofi Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Roche Holding AG
11.6.1 Roche Holding AG Company Details
11.6.2 Roche Holding AG Business Overview
11.6.3 Roche Holding AG 5HT3 Receptor Antagonists Introduction
11.6.4 Roche Holding AG Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.6.5 Roche Holding AG Recent Developments
11.7 Kyowa Kirin
11.7.1 Kyowa Kirin Company Details
11.7.2 Kyowa Kirin Business Overview
11.7.3 Kyowa Kirin 5HT3 Receptor Antagonists Introduction
11.7.4 Kyowa Kirin Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.7.5 Kyowa Kirin Recent Developments
11.8 Heron Therapeutics
11.8.1 Heron Therapeutics Company Details
11.8.2 Heron Therapeutics Business Overview
11.8.3 Heron Therapeutics 5HT3 Receptor Antagonists Introduction
11.8.4 Heron Therapeutics Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.8.5 Heron Therapeutics Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline 5HT3 Receptor Antagonists Introduction
11.9.4 GlaxoSmithKline Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.9.5 GlaxoSmithKline Recent Developments
11.10 Fortovia Therapeutics
11.10.1 Fortovia Therapeutics Company Details
11.10.2 Fortovia Therapeutics Business Overview
11.10.3 Fortovia Therapeutics 5HT3 Receptor Antagonists Introduction
11.10.4 Fortovia Therapeutics Revenue in 5HT3 Receptor Antagonists Business (2017-2022)
11.10.5 Fortovia Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global 5HT3 Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Dolasetron
Table 3. Key Players of Granisetron
Table 4. Key Players of Ondansetron
Table 5. Key Players of Palonosetron
Table 6. Global 5HT3 Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global 5HT3 Receptor Antagonists Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global 5HT3 Receptor Antagonists Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global 5HT3 Receptor Antagonists Market Share by Region (2017-2022)
Table 10. Global 5HT3 Receptor Antagonists Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global 5HT3 Receptor Antagonists Market Share by Region (2023-2028)
Table 12. 5HT3 Receptor Antagonists Market Trends
Table 13. 5HT3 Receptor Antagonists Market Drivers
Table 14. 5HT3 Receptor Antagonists Market Challenges
Table 15. 5HT3 Receptor Antagonists Market Restraints
Table 16. Global 5HT3 Receptor Antagonists Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global 5HT3 Receptor Antagonists Revenue Share by Players (2017-2022)
Table 18. Global Top 5HT3 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 5HT3 Receptor Antagonists as of 2021)
Table 19. Ranking of Global Top 5HT3 Receptor Antagonists Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by 5HT3 Receptor Antagonists Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players 5HT3 Receptor Antagonists Product Solution and Service
Table 23. Date of Enter into 5HT3 Receptor Antagonists Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global 5HT3 Receptor Antagonists Revenue Market Share by Type (2017-2022)
Table 27. Global 5HT3 Receptor Antagonists Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global 5HT3 Receptor Antagonists Revenue Market Share by Type (2023-2028)
Table 29. Global 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global 5HT3 Receptor Antagonists Revenue Share by Application (2017-2022)
Table 31. Global 5HT3 Receptor Antagonists Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global 5HT3 Receptor Antagonists Revenue Share by Application (2023-2028)
Table 33. North America 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America 5HT3 Receptor Antagonists Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America 5HT3 Receptor Antagonists Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America 5HT3 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America 5HT3 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe 5HT3 Receptor Antagonists Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe 5HT3 Receptor Antagonists Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe 5HT3 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe 5HT3 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific 5HT3 Receptor Antagonists Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific 5HT3 Receptor Antagonists Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific 5HT3 Receptor Antagonists Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific 5HT3 Receptor Antagonists Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America 5HT3 Receptor Antagonists Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America 5HT3 Receptor Antagonists Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America 5HT3 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America 5HT3 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa 5HT3 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million)
Table 63. Otsuka Pharmaceutical Company Details
Table 64. Otsuka Pharmaceutical Business Overview
Table 65. Otsuka Pharmaceutical 5HT3 Receptor Antagonists Product
Table 66. Otsuka Pharmaceutical Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 67. Otsuka Pharmaceutical Recent Developments
Table 68. MedKoo Biosciences Company Details
Table 69. MedKoo Biosciences Business Overview
Table 70. MedKoo Biosciences 5HT3 Receptor Antagonists Product
Table 71. MedKoo Biosciences Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 72. MedKoo Biosciences Recent Developments
Table 73. Cipla Company Details
Table 74. Cipla Business Overview
Table 75. Cipla 5HT3 Receptor Antagonists Product
Table 76. Cipla Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 77. Cipla Recent Developments
Table 78. Helsinn Healthcare SA Company Details
Table 79. Helsinn Healthcare SA Business Overview
Table 80. Helsinn Healthcare SA 5HT3 Receptor Antagonists Product
Table 81. Helsinn Healthcare SA Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 82. Helsinn Healthcare SA Recent Developments
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi 5HT3 Receptor Antagonists Product
Table 86. Sanofi Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 87. Sanofi Recent Developments
Table 88. Roche Holding AG Company Details
Table 89. Roche Holding AG Business Overview
Table 90. Roche Holding AG 5HT3 Receptor Antagonists Product
Table 91. Roche Holding AG Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 92. Roche Holding AG Recent Developments
Table 93. Kyowa Kirin Company Details
Table 94. Kyowa Kirin Business Overview
Table 95. Kyowa Kirin 5HT3 Receptor Antagonists Product
Table 96. Kyowa Kirin Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 97. Kyowa Kirin Recent Developments
Table 98. Heron Therapeutics Company Details
Table 99. Heron Therapeutics Business Overview
Table 100. Heron Therapeutics 5HT3 Receptor Antagonists Product
Table 101. Heron Therapeutics Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 102. Heron Therapeutics Recent Developments
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline 5HT3 Receptor Antagonists Product
Table 106. GlaxoSmithKline Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 107. GlaxoSmithKline Recent Developments
Table 108. Fortovia Therapeutics Company Details
Table 109. Fortovia Therapeutics Business Overview
Table 110. Fortovia Therapeutics 5HT3 Receptor Antagonists Product
Table 111. Fortovia Therapeutics Revenue in 5HT3 Receptor Antagonists Business (2017-2022) & (US$ Million)
Table 112. Fortovia Therapeutics Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global 5HT3 Receptor Antagonists Market Share by Type: 2021 VS 2028
Figure 2. Dolasetron Features
Figure 3. Granisetron Features
Figure 4. Ondansetron Features
Figure 5. Palonosetron Features
Figure 6. Global 5HT3 Receptor Antagonists Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Drugstore Case Studies
Figure 9. Others Case Studies
Figure 10. 5HT3 Receptor Antagonists Report Years Considered
Figure 11. Global 5HT3 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global 5HT3 Receptor Antagonists Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global 5HT3 Receptor Antagonists Market Share by Region: 2021 VS 2028
Figure 14. Global 5HT3 Receptor Antagonists Market Share by Players in 2021
Figure 15. Global Top 5HT3 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 5HT3 Receptor Antagonists as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by 5HT3 Receptor Antagonists Revenue in 2021
Figure 17. North America 5HT3 Receptor Antagonists Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America 5HT3 Receptor Antagonists Market Size Market Share by Type (2017-2028)
Figure 19. North America 5HT3 Receptor Antagonists Market Size Market Share by Application (2017-2028)
Figure 20. North America 5HT3 Receptor Antagonists Market Size Share by Country (2017-2028)
Figure 21. United States 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe 5HT3 Receptor Antagonists Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe 5HT3 Receptor Antagonists Market Size Market Share by Type (2017-2028)
Figure 25. Europe 5HT3 Receptor Antagonists Market Size Market Share by Application (2017-2028)
Figure 26. Europe 5HT3 Receptor Antagonists Market Size Share by Country (2017-2028)
Figure 27. Germany 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific 5HT3 Receptor Antagonists Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific 5HT3 Receptor Antagonists Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific 5HT3 Receptor Antagonists Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific 5HT3 Receptor Antagonists Market Size Share by Region (2017-2028)
Figure 37. China 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America 5HT3 Receptor Antagonists Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America 5HT3 Receptor Antagonists Market Size Market Share by Type (2017-2028)
Figure 45. Latin America 5HT3 Receptor Antagonists Market Size Market Share by Application (2017-2028)
Figure 46. Latin America 5HT3 Receptor Antagonists Market Size Share by Country (2017-2028)
Figure 47. Mexico 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa 5HT3 Receptor Antagonists Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa 5HT3 Receptor Antagonists Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa 5HT3 Receptor Antagonists Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa 5HT3 Receptor Antagonists Market Size Share by Country (2017-2028)
Figure 53. Turkey 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE 5HT3 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Otsuka Pharmaceutical Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 57. MedKoo Biosciences Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 58. Cipla Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 59. Helsinn Healthcare SA Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 61. Roche Holding AG Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 62. Kyowa Kirin Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 63. Heron Therapeutics Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 64. GlaxoSmithKline Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 65. Fortovia Therapeutics Revenue Growth Rate in 5HT3 Receptor Antagonists Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Global SERD (Selective Estrogen Receptor Degrader) Drugs Market Insights, Forecast to 2028
QY2207E09282 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のSERD（選択エストロゲン受容体分解）薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021...

ガンマアミノ酪酸（GABA）受容体アゴニストのグローバル市場インサイト・予測（～2028年）

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Insights, Forecast to 2028
QY2207C3462 2022年7月11日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界のガンマアミノ酪酸（GABA）受容体アゴニストの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...

オピオイド受容体アゴニストのグローバル市場インサイト・予測（～2028年）

Global Opioid Receptor Agonist Market Insights, Forecast to 2028
QY2207E10435 2022年7月 117Pages
新型コロナウイルス感染症のパンデミックにより、世界のオピオイド受容体アゴニストの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオピオイド...

5-ヒドロキシトリプタミン受容体アゴニストのグローバル市場インサイト・予測（～2028年）

Global 5-Hydroxytryptamine Receptor Agonist Market Insights, Forecast to 2028
QY2207E09210 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界の5-ヒドロキシトリプタミン受容体アゴニストの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

世界の先端巨大症・巨人症治療薬市場予測（～2028年）：ソマトスタチン類似体、GH受容体拮抗薬、ドーパミン作動薬、組換えヒトIGF-1

Global Acromegaly and Gigantism Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8715 2022年5月 71Pages
先端巨大症・巨人症治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供し...

5-ヒドロキシトリプタミン受容体アゴニストのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global 5-Hydroxytryptamine Receptor Agonist Market Due to the COVID-19 pandemic, the global 5-Hydroxytryptamine Receptor Agonist market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during …
ガンマアミノ酪酸（GABA）受容体アゴニストのグローバル市場インサイト・予測（～2028年） Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders. Market Analysis and Insights…
SERD（選択エストロゲン受容体分解）薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global SERD (Selective Estrogen Receptor Degrader) Drugs Market The global SERD (Selective Estrogen Receptor Degrader) Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic …
オピオイド受容体アゴニストのグローバル市場インサイト・予測（～2028年） Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a stron…
配合滅菌製剤薬局のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Compounded Sterile Preparations Pharmacy Market The global Compounded Sterile Preparations Pharmacy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this hea…